About
Dr. Joseph Tucker joined Ventac Partners as Partner in December 2015. He has more than 15 years experience in senior life science and finance roles in both the United States and Canada. Key past executive positions include Chief Executive Officer at Stem Cell Therapeutics Inc. and Pharmavation Inc., Chief Financial Officer at SolAeroMed Inc., and Vice President at Resverlogix Inc. and Neurostasis Inc. Joseph began his career as a health care stock market analyst. Dr. Tucker’s core skills lie in executive management, company creation, business development, and intellectual property protection. As Chief Executive Officer and co-founder of Stem Cell Therapeutics, Joseph led the company through several rounds of fund-raising and a successful Initial Public Offering. Other exits of co-founded companies include the out-licensing of Pharmavation to Affectis and the sale of Neurostasis to Transition Therapeutics. Dr. Tucker is also an inventor of more than 20 issued or pending patents. Curre
Position in the VCSift Database
- • 14 investors at Ventac Partners are tracked.
- • 2,531 investors hold the Partner role in VCSift. Joseph Tucker is one of them.
- • 2,293 investors are based in Boston, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Boston, US
Contact Information
Find more investors like Joseph
Search Investors